Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease

EMBO Molecular Medicine

Volumn 6, Issue 11, 2014, Pages 1423-1435

  Bilbao, Daniel ^a   Luciani, Luisa ^a,d   Johannesson, Bjarki ^a   Piszczek, Agnieszka ^a,e   Rosenthal, Nadia ^a,b,c  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MIAMI   (United States)

^e INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

Author keywords

Autoimmunity; Diabetes; IGF 1; Multiple sclerosis; T regulatory cells

Indexed keywords

RECOMBINANT SOMATOMEDIN C; STREPTOZOCIN; RECOMBINANT PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OSMOTIC MINIPUMP; REGULATORY T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASES; BIOLOGICAL THERAPY; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE COURSE; DRUG EFFECTS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL THERAPY; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE, INBRED C57BL; MICE, INBRED NOD; MULTIPLE SCLEROSIS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

EID: 84910651421     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201303376     Document Type: Article

References (72)

1. Agudo J, Ayuso E, Jimenez V, Salavert A, Casellas A, Tafuro S, Haurigot V, Ruberte J, Segovia JC, Bueren J et al (2008) IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia 51: 1862-1872
2. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485
3. Anguela XM, Tafuro S, Roca C, Callejas D, Agudo J, Obach M, Ribera A, Ruzo A, Mann CJ, Casellas A et al (2013) Nonviral-mediated hepatic expression of IGF-I increases Treg levels and suppresses autoimmune diabetes in mice. Diabetes 62: 551-560
4. Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5: 601-604
5. Bergerot I, Fabien N, Maguer V, Thivolet C (1995) Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes. Clin Exp Immunol 102: 335-340
6. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300
7. Bromley SK, Mempel TR, Luster AD (2008) Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol 9: 970-980
8. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, Sefik E, Tan TG, Wagers AJ, Benoist C et al (2013) A special population of regulatory T cells potentiates muscle repair. Cell 155: 1282-1295
9. van Buul-Offers SC, Kooijman R (1998) The role of growth hormone and insulin-like growth factors in the immune system. Cell Mol Life Sci 54: 1083-1094
10. Campbell DJ, Koch MA (2011) Treg cells: patrolling a dangerous neighborhood. Nat Med 17: 929-930
11. Cannella B, Pitt D, Capello E, Raine CS (2000) Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination. Am J Pathol 157: 933-943
12. Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL (1998) Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment. Clin Endocrinol 49: 739-746
13. Casellas A, Salavert A, Agudo J, Ayuso E, Jimenez V, Moya M, Muñoz S, Franckhauser S, Bosch F (2006) Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes. Diabetes 55: 3246-3255
14. Chen W, Salojin KV, Mi QS, Grattan M, Meagher TC, Zucker P, Delovitch TL (2004) Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 145: 627-638
15. Cockfield SM, Ramassar V, Urmson J, Halloran PF (1989) Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 142: 1120-1128
16. Duncan DT, Prodduturi N, Zhang B (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11(Suppl. 4): 10
17. Efstratiadis A, Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205: 1983-1991
18. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D (2009) How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31: 654-664
19. + regulatory T cells in the steady state. J Exp Med 198: 737-746
20. Genoud S, Maricic I, Kumar V, Gage FH (2005) Target expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis. J Neuroimmunol 168: 40-45
21. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F (2002) Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109: 1153-1163
22. Heikkinen S, Argmann CA, Champy MF, Auwerx J (2007) Evaluation of glucose homeostasis. Curr Protoc Mol Biol Chapter 29:Unit 29B.3
23. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199: 1479-1489
24. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C (2007) Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800
25. Johannesson B, Sattler S, Semenova E, Pastore S, Kennedy-Lydon T, Sampson R, Schneider MD, Rosenthal N, Bilbao D (2014) Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice. Dis Model Mech 7: 977-985
26. Johnson DG, Schwartz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352
27. Kaino Y, Hirai H, Ito T, Kida K (1996) Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice. Diabetes Res Clin Pract 34: 7-11
28. Klekotka PA, Yang L, Yokoyama WM (2010) Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J Invest Dermatol 130: 184-191
29. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Bäckström BT, Sobel RA, Wucherpfennig KW, Strom TB et al (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423-431
30. Le Roith D (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336: 633-640
31. Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216-226
32. LeRoith D, Yakar S (2007) Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3: 302-310
33. Like AA, Rosini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193: 415-417
34. Linn T, Volkmann A, Germann H, Woehrle M, Bretzel RG, Bicker U, Federlin K (1987) Ciamexon in the low dose streptozotocin induced diabetes of mice. Diabetes Res 6: 113-117
35. Littman DR, Rudensky AY (2010) Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858
36. Liu X, Linnington C, Webster HD, Lassmann S, Yao DL, Hudson LD, Wekerle H, Kreutzberg GW (1997) Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis. J Neurosci Res 47: 531-538
37. Long SA, Buckner JH, Greenbaum CJ (2013) IL-2 therapy in type 1 diabetes: "Trials" and tribulations. Clin Immunol 149: 324-331
38. Lovett-Racke AE, Bittner P, Cross AH, Carlino JA, Racke MK (1998) Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3). J Clin Invest 101: 1797-1804
39. Lukić ML, Stosić-Grujicić S, Shahin A (1998) Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 6: 119-128
40. Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2: 816-822
41. Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, Paul WE (2007) Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol 37: 1916-1923
42. Morrow LA, O'Brien MB, Moller DE, Flier JS, Moses AC (1994) Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab 79: 205-210
43. Musaro A, Giacinti C, Borsellino G, Dobrowolny G, Pelosi L, Cairns L, Ottolenghi S, Cossu G, Bernardi G, Battistini L et al (2004) Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA 101: 1206-1210
44. Nakamura M, Nagafuchi S, Yamaguchi K, Takaki R (1984) The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice. Diabetes 33: 894-900
45. O'Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801-805
46. O'Leary MT, Hinks GL, Charlton HM, Franklin RJ (2002) Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol Cell Neurosci 19: 32-42
47. Paik S, Fleischer N, Shin S (1980) Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci USA 77: 6129-6133
48. Papaccio G, Latronico M, Chieffi Baccari G (1994) The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin. Cell Tissue Res 277: 573-578
49. Quattrin T, Thrailkill K, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Giltinan D, Gesundheit N, Martha P Jr (1997) Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Diabetes Care 20: 374-380
50. Richmond EJ, Rogol AD (2008) Recombinant human insulin-like growth factor-I therapy for children with growth disorders. Adv Ther 25: 1276-1287
51. Rossini AA, Williams RM, Appel MC, Like AA (1978) Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature 276: 182-184
52. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, Mathis D, Benoist C, Rudensky AY (2010) Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671
53. Sakaguchi S, Wing K, Miyara M (2007) Regulatory T cells - a brief history and perspective. Eur J Immunol 37(Suppl. 1): S116-S123
54. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, Bonner-Weir S (1991) Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA 88: 6152-6156
55. Smith TJ (2010) Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev 62: 199-236
56. Stosić-Grujicić S, Cvjetićanin T, Stojanović I (2009) Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. Mol Immunol 47: 79-86
57. Stromnes IM, Goverman JM (2006) Active induction of experimental allergic encephalomyelitis. Nat Protoc 1: 1810-1819
58. Temmerman L, Slonimsky E, Rosenthal N (2010) Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels. Growth Hormon IGF Res 20: 255-263
59. +) T cells promotes diabetes. J Leukoc Biol 84: 431-439
60. Wan YY, Flavell RA (2007) Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770
61. + T cells. Eur J Immunol 37: 129-138
62. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J (2009) In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206: 751-760
63. Wen Y, Ouyang J, Li W, Chen J, Liu Y, Meng L, Zhang H, Zhou X (2009) Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice. Transplant Proc 41: 1801-1807
64. Williams LM, Rudensky AY (2007) Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8: 277-284
65. Wing K, Sakaguchi S (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7-13
66. Yanagawa T, Maruyama T, Takei I, Asaba Y, Takahashi T, Ishii T, Kataoka K, Saruta T, Minoshima S, Shimizu N (1989) The suppressive effect of cyclophosphamide on low-dose streptozotocin-induced diabetes in mice. Diabetes Res 12: 79-83
67. Yao DL, Liu X, Hudson LD, Webster HD (1995) Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 92: 6190-6194
68. Yaturu S (2013) Insulin therapies: current and future trends at dawn. World J Diabetes 4: 1-7
69. Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML, Mensah-Brown EP (2009) Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. Mol Immunol 47: 28-36
70. Zenobi PD, Graf S, Ursprung H, Froesch ER (1992) Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 89: 1908-1913
71. Zhang B, Kirov SA, Snoddy JR (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-W748
72. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10: 1000-1007